Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan B King

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Journal of Human Hypertension|July 4, 2026
Patient out-of-pocket costs for antihypertensive single pill combination products with cost capsCatherine G Derington, Kyle Tong, Joshua A Jacobs, et al.
Journal of the American Heart Association|July 23, 2020
Impact of Self-Monitoring of Blood Pressure on Processes of Hypertension Care and Long-Term Blood Pressure ControlKelsey B Bryant, James P Sheppard, Natalia Ruiz-Negrón, et al.
Journal of the American Heart Association|January 19, 2024
Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial)Joshua A Jacobs, Catherine G Derington, Alexander R Zheutlin, et al.
The American Journal of Cardiology|October 8, 2018
Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina PectorisAdam P Bress, John A Dodson, Jordan B King, et al.
Journal of the American Heart Association|August 30, 2023
New Users of Angiotensin II Receptor Blocker-Versus Angiotensin-Converting Enzyme Inhibitor-Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD-BP and SPRINTJordan B King, Ransmond O Berchie, Catherine G Derington, et al.
Hypertension (Dallas, Tex. : 1979)|September 4, 2024
Use and Cost Patterns of Antihypertensive Medications in the United States From 1996 to 2021Joshua A Jacobs, Anthony Rodgers, Brandon K Bellows, et al.
Circulation. Heart Failure|November 14, 2019
Characteristics and Healthcare Utilization Among Veterans Treated for Heart Failure With Reduced Ejection Fraction Who Switched to Sacubitril/ValsartanApril F Mohanty, Emily B Levitan, John A Dodson, et al.
JAMA Network Open|October 20, 2025
Medicare Part D Use and Costs for Immune-Mediated Neurologic TherapiesKa-Ho Wong, Esther Zeng, Tammy L Smith, et al.
JAMA Network Open|January 10, 2022
Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical TrialAlexander R Zheutlin, Favel L Mondesir, Catherine G Derington, et al.
Journal of the American Heart Association|August 1, 2019
Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable AnginaMina Owlia, John A Dodson, Jordan B King, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Journal of Human Hypertension|July 4, 2026
Patient out-of-pocket costs for antihypertensive single pill combination products with cost capsCatherine G Derington, Kyle Tong, Joshua A Jacobs, et al.
Journal of the American Heart Association|July 23, 2020
Impact of Self-Monitoring of Blood Pressure on Processes of Hypertension Care and Long-Term Blood Pressure ControlKelsey B Bryant, James P Sheppard, Natalia Ruiz-Negrón, et al.
Journal of the American Heart Association|January 19, 2024
Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial)Joshua A Jacobs, Catherine G Derington, Alexander R Zheutlin, et al.
The American Journal of Cardiology|October 8, 2018
Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina PectorisAdam P Bress, John A Dodson, Jordan B King, et al.
Journal of the American Heart Association|August 30, 2023
New Users of Angiotensin II Receptor Blocker-Versus Angiotensin-Converting Enzyme Inhibitor-Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD-BP and SPRINTJordan B King, Ransmond O Berchie, Catherine G Derington, et al.
Hypertension (Dallas, Tex. : 1979)|September 4, 2024
Use and Cost Patterns of Antihypertensive Medications in the United States From 1996 to 2021Joshua A Jacobs, Anthony Rodgers, Brandon K Bellows, et al.
Circulation. Heart Failure|November 14, 2019
Characteristics and Healthcare Utilization Among Veterans Treated for Heart Failure With Reduced Ejection Fraction Who Switched to Sacubitril/ValsartanApril F Mohanty, Emily B Levitan, John A Dodson, et al.
JAMA Network Open|October 20, 2025
Medicare Part D Use and Costs for Immune-Mediated Neurologic TherapiesKa-Ho Wong, Esther Zeng, Tammy L Smith, et al.
JAMA Network Open|January 10, 2022
Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical TrialAlexander R Zheutlin, Favel L Mondesir, Catherine G Derington, et al.
Journal of the American Heart Association|August 1, 2019
Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable AnginaMina Owlia, John A Dodson, Jordan B King, et al.
Pageof 7